Kerstin Stenson to Immunotherapy
This is a "connection" page, showing publications Kerstin Stenson has written about Immunotherapy.
Connection Strength
0.192
-
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma. Head Neck. 2021 12; 43(12):3875-3887.
Score: 0.192